JHMD - ETF AI Analysis

Top Page

John Hancock Multifactor Developed International ETF (JHMD)

Rating:65Neutral

Price Target:―

JHMD’s rating suggests it is a solid but not top-tier developed international ETF, supported by strong core holdings like Novartis and HSBC, which bring robust financial performance, reasonable valuations, and positive earnings sentiment. However, weaker names such as BASF and E.ON, which face profitability and cash flow challenges and only neutral technical trends, likely hold the fund back somewhat. The main risk factor is exposure to several companies with valuation or overbought concerns, which could increase volatility if market conditions turn.

Positive Factors

Improving Recent Performance

The ETF has shown steady gains over the past three months and month-to-date, indicating positive recent momentum.

Broad Country Diversification

Holdings spread across many developed markets like Japan, the UK, Germany, and others help reduce the impact of weakness in any single country.

Supportive Top Holdings

Several of the largest positions, including ASML, Novartis, HSBC, Roche, E.ON, and Engie, have delivered strong or steady year-to-date results that support the fund’s overall performance.

Negative Factors

Moderate Expense Ratio

The fund’s expense ratio is not especially low for an ETF, which slightly reduces the net return investors keep over time.

Mixed Performance Among Top Holdings

Some key positions such as Vinci, Shell, and BASF have shown weaker year-to-date performance, which can drag on the fund’s returns.

Heavy Tilt Toward Financials and Industrials

Large weights in financial and industrial stocks mean the ETF could be more sensitive if these sectors face a downturn.

JHMD vs. SPDR S&P 500 ETF (SPY)

AUM1.19B

RegionDeveloped Markets

Expense Ratio0.39%

Beta0.66

IssuerJohn Hancock

Inception DateDec 15, 2016

Dividend Yield2.94%

Asset ClassEquity

Index TrackedJohn Hancock Dimensional Developed International Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume181,128

30 Day Avg. Volume184,604

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

48.48

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering581

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

JHMD Summary

John Hancock Multifactor Developed International ETF (JHMD) tracks the John Hancock Dimensional Developed International Index, giving you broad exposure to stocks in developed countries outside the U.S., such as Japan, the UK, and Germany. It owns many types of companies across sectors, including well-known names like ASML Holding and Novartis. Investors might consider JHMD to diversify beyond the U.S. market and spread risk across many international industries and company sizes. A key risk is that international stocks can be volatile and are affected by foreign economies, currencies, and political events, so the value can go up and down.

How much will it cost me?The John Hancock Multifactor Developed International ETF (JHMD) has an expense ratio of 0.39%, which means you’ll pay $3.90 per year for every $1,000 invested. This cost is slightly higher than average for passively managed ETFs because it uses a multifactor strategy to optimize risk and reward across developed international markets.

What would affect this ETF?Positive drivers for JHMD include potential economic growth in developed international markets outside North America, which could boost the performance of its top holdings like Vinci SA and Novartis AG. However, negative factors such as rising interest rates or economic slowdowns in Europe could impact sectors like Financials and Industrials, which make up a significant portion of the ETF's exposure.

JHMD Top 10 Holdings

JHMD’s story is all about developed markets overseas, with no U.S. exposure and a tilt toward financials, industrials, and utilities rather than flashy Big Tech. ASML is one of the key engines, rising steadily and giving the fund a lift from the semiconductor space. European banks like HSBC and BBVA are also helping, with HSBC in particular adding momentum. On the flip side, infrastructure player Vinci has been lagging, and Shell has been more of a steady cruiser than a speedboat, slightly muting the fund’s overall upside.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
0NQM	Vinci SA	1.75%	$20.98M	€76.89B	28.74%	76 Outperform
ASML	ASML Holding NV	1.65%	$19.75M	€475.49B	74.46%	76 Outperform
NOVN	Novartis AG	1.64%	$19.67M	CHF242.43B	28.84%	80 Outperform
SHEL	Shell (UK)	1.22%	$14.66M	£165.51B	11.49%	73 Outperform
BBVA	Banco Bilbao Vizcaya Argentaria	0.97%	$11.56M	€113.89B	59.02%	76 Outperform
HSBA	HSBC Holdings	0.92%	$11.01M	£222.90B	45.63%	80 Outperform
BAS	BASF SE	0.89%	$10.62M	€44.55B	1.13%	61 Neutral
ROG	Roche Holding AG	0.86%	$10.30M	CHF294.84B	46.01%	73 Outperform
ENGI	Engie SA	0.81%	$9.75M	€64.94B	64.26%	64 Neutral
EOAN	E.ON SE	0.81%	$9.68M	€48.56B	59.74%	61 Neutral

JHMD Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

42.87

Positive

100DMA

41.33

Positive

200DMA

39.55

Positive

Market Momentum

MACD

0.76

Positive

RSI

68.82

Neutral

STOCH

73.45

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For JHMD, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 44.48, equal to the 50-day MA of 42.87, and equal to the 200-day MA of 39.55, indicating a bullish trend. The MACD of 0.76 indicates Positive momentum. The RSI at 68.82 is Neutral, neither overbought nor oversold. The STOCH value of 73.45 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JHMD.

JHMD Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
JHMD	―	―	$1.19B	0.39%	―
DBEF	―	―	$8.74B	0.35%	―
FENI	―	―	$8.16B	0.28%	―
BBIN	―	―	$6.42B	0.07%	―
EFAV	―	―	$5.67B	0.20%	―
IHDG	―	―	$2.36B	0.58%	―

Performance Comparison

JHMD

John Hancock Multifactor Developed International ETF

45.50

11.97

35.70%

DBEF

Xtrackers MSCI EAFE Hedged Equity ETF

―

FENI

Fidelity Enhanced International ETF

―

BBIN

JPMorgan BetaBuilders International Equity ETF

―

EFAV

iShares MSCI EAFE Min Vol Factor ETF

―

IHDG

WisdomTree International Hedged Quality Dividend Growth Fund

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents